Copyright
©The Author(s) 2017.
World J Gastroenterol. Jan 7, 2017; 23(1): 42-47
Published online Jan 7, 2017. doi: 10.3748/wjg.v23.i1.42
Published online Jan 7, 2017. doi: 10.3748/wjg.v23.i1.42
Antibiotics | Dosages |
Adults with NE | |
Monotherapy | |
Piperacillin-tazobactam | 3.375 g IV every 6 h |
Imipenem-cillastin | 500 mg IV every 6 h or 1 g IV every 6-8 h |
Duotherapy | |
Ceftazidime | 1 g IV every 8-12 h |
OR | OR |
Cefepime | 1 g IV every 8 h |
Plus Metronidazole | 1 g IV every 6 h |
Children ( 1-12 yr of age) with NE | |
Monotherapy | |
Piperacillin-tazobactam | (> 9 mo and < 40 kg) 300 mg/kg per day IV divided every 8 h |
Imipenem-cillastin | (> 3 mo) 60-100 mg/kg per day IV divided every 6 h maximum 2-4 g/d |
Duotherapy | |
Ceftazidime | 90-150 mg/kg per day IV divided every 8 h - maximum 6 g/d or |
OR | 50 mg/kg IV every 8 h - maximum: 2 g/dose |
Cefepime | |
Plus Metronidazole | 30 mg/kg per day IV divided every 6 h - maximum 4 g/d |
- Citation: Rodrigues FG, Dasilva G, Wexner SD. Neutropenic enterocolitis. World J Gastroenterol 2017; 23(1): 42-47
- URL: https://www.wjgnet.com/1007-9327/full/v23/i1/42.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i1.42